DDX3X and chronic myelogenous leukemia, BCR-ABL1 positive: Evidence showed that DDX3X is overexpressed in glioblastoma, medulloblastoma, gallbladder carcinoma, pancreatic ductal adenocarcinoma and chronic myeloid leukemia [42,43].